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Purpose: Forty-one months after we performed bilateral implantation of in vitro endothe- 
lialized femoropopliteal bypass grafts in a 69-year-old patient, we obtained acentral graft 
segment for histologic and ultrastructural investigation. 
Methods: Before implantation the grafts were confluently lined with autologous first passage 
mass cultures of pure cephalic vein endothelial cells. The precoating of the expanded polytet- 
rafluoroethylene prosthesis was done with fibrinolytically inhibited fibrin glue. Reoperation 
became necessary because of symptomatic unilateral atherosderotic lesions located in the 
center of one of the two in vitro lined grafts. A 21 cm long graft segment was removed and 
replaced by a new in vitro endothelialized xpanded polytetrafluoroethylene graft. 
Results: On scanning electron microscopy a confluently covering mature ndothelium was 
found throughout the whole length of the removed prosthesis. The endothelial identity 
was confirmed by a positive immunohistochemical CD 34, von Willebrand factor- 
staining, and the ultrastructural demonstration of Weibel Pallade bodies. The endothe- 
lium rested on a collagen IV positive basement membrane. Histologic cross sections 
revealed uniformly developed subintimal tissue of 1.21 - 0.19 rnm thickness, which was 
separated from the intima by a distinct internal elastic membrane. The cells of this 
cell-rich matrix stained strongly positive for actin. Ultrastructurally, this matrix was 
dominated by highly contractile myofibroblasts loaded with peripherally located well- 
developed actin f-filaments. A number of these cells also showed signs of secretory cells 
with a distinct endoplasmic reticulum and a Golgi complex. In areas of atherosclerotic 
lesions the subendothelial matrix was partially exposed, and the internal elastic mem- 
brane had to a certain extent disintegrated. Only in these areas KP-1 and MG-M1 
positive foamy macrophages and CD 34 positive capillaries were found. The myofibro- 
blasts of this diseased part of the subintimal tissue contained large lipid vacuoles. 
Conclusions: We conclude that the confluent in vitro lining of synthetic vascular grafts 
with pure autologous endothelial cells facilitates graft healing, which may result in a 
hybrid structure with features of a native vessel. (J Vasc Surg 1997;25:757-63.) 
Endothelial cell seeding was first developed in the 
late 1970s in an attempt to overcome the inability of 
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prosthetic vascular grafts to spontaneously endothe- 
lialize after implantation. 1 Despite numerous suc- 
cessful animal experiments with this single-staged 
method, which is based on the intraoperative har- 
vesting of  venous endothelial cells, human trials 
failed because of an insufficient seeding density. 2As a 
consequence two alternative techniques evolved that 
resulted in a much higher cell inoculum" microvascu- 
lar seeding 3 and in vitro lining of  prosthetic graft 
surfaces with cultured autologous endothelial cells. 4 
We have previously shown that in vitro endothe- 
lialization results in improved clinical graft patency, s 
With the morphologic investigation of a 41-month 
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Fig. 1. Angiographic picture of bilateral in vitro endothe- 
lialized femoropopliteal bypass grafts 41 months after im- 
plantation. Completely smooth surface was found in right- 
sided graft, whereas irregularities in mid and proximal third 
of graft caused more than 75% stenosis of cross-sectional 
area on left side. 
explant from a patient, we finally had the opportunity 
to elucidate the long-term fate of  in vitro endotheli- 
alized grafts in humans. 
CASE REPORT 
The patient we report here belongs to our clinical in 
vitro endothelialization trial, s He was a 69-year-old man 
with bilateral disabling claudication (grade I/Fontain IIb). 
Because of previous coronary artery bypass grafting both 
saphenous veins had already been taken. These criteria 
qualified him for our trial. His risk factors were smoking 
(90 pack years), hypercholesterinemia (8.7 mmol/L) ,  and 
non-insulin-dependent diabetes. 
In a staged procedure two in vitro endothelialized 
bypass grafts were bilaterally inserted in the above-knee 
position. The right-sided graft had a length of 55 cm and 
the left-sided graft, 52 cm+ 
The patient had no symptoms until 38 months after 
implantation. After 12 and 24 months routine angiography 
did not show any stenoses throughout both grafts includ- 
ing the anastomoses. At 36 months the surface of the tight 
graft was still completely smooth, whereas irregular appo- 
sitions were seen in the middle segment and the central 
part of the distal third of the left one. At that time the 
ankle-brachial index on the left side had dropped from 
0.89 to 0.78, whereas the tight one remained at 0.95. 
When progredient claudication prompted the patient to 
come for an unscheduled follow-up 5 months later, a 
further significant decrease of the ABI to 0.59 had oc- 
curred on the left side. Another angiography was initiated, 
which again demonstrated an unaltered right-sided pros- 
thesis but a markedly increased stenosis on the left side. In 
one segment he graft was narrowed to <75% cross-sec- 
tional area, and a few less pronounced surface irregularities 
were found further distally (Fig. 1). 
After the decision to reoperate was made, another vein 
segment was taken from the fbrearm, and a new graft 
underwent in vitro endothelialization. The explanation of a 
21 cm long segment of the left-sided bypass graft contain- 
ing the stenosed area and an end-to-end interposition of 
the new endothelialized graft were done 28 days after vein 
excision. 
GRAFT  ENDOTHEL IAL IZAT ION 
The culture technique for autologous endothelial 
cells 6 and the lining procedure of  the thin-walled, 
ring-reinforced 6 mm expanded polytetrafluoro- 
ethylene (ePTFE) grafts (W. L. Gore, Flagstaff, 
Ariz.) 4'5'7 have been extensively described before. In 
brief, two segments of  the cephalic vein were used as 
cell sources for autologous endothelial cells. After 
no-touch dissection was performed with the patient 
under local anesthesia (1% Lignocaine, Linz, Aus- 
tria), the veins were in situ cannulated before they 
were filled with collagenase (0.1% CLS I I ,  Cooper,  
Malvern, Pa.). 6 Each primary culture was grown in 
one well o f  a six-well plate (Costar, Cambridge,  
Mass.) and was passaged at confluence into two 162 
cm 2 culture flasks (Costar). A microgrid technique 
enabled the daily in situ quantification of  available 
endothelial cells. 6 Two 6 mm expanded PTFE grafts 
70 cm long were preclotted with a special dilution of  
clinically approved and fibrinolytically inhibited fi- 
brin glue ( Immuno AG, Vienna, Austria). 4'7 After 
coating was performed, the grafts were further pre- 
treated with virologically tested fibronectin (6 mg/  
cm 2, 2 hours, room temperature, Innotech,  Ziirich, 
Switzerland). Before lining was performed, a control 
specimen was taken from each graft and processed 
for scanning electron microscopy (SEM) and light 
microscopy to assess the completeness and thickness 
of  the fibrin glue layer. Grafts were then t r immed to 
60 cm length, filled with the cell suspension, and 
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rotated in a microprocessor-controlled s eding de- 
vice at 6 rph for 3 hours. 4Subsequently both ends of 
the grafts were further trimmed to remove those 
segments where the clamps of the rotation device 
had prevented endothelialization. Then the grafts 
were incubated in a specially designed filter-pro- 
tected culture vessel containing 4 ml of complete 
medium per square centimeter graft surf]Ice. 4After a 
further incubation period of 12 days (left-sided graft) 
and 9 days (right-sided graft) to allow the maturation 
of the cytoskelcton, grafts were implanted. 
H ISTOLOGIC AND ULTRASTRUCTURAL 
INVESTIGATIONS 
Control specimens for light-microscopy and 
SEM were taken at the end of the precoating proce- 
dure immediately after seeding and before implanta- 
tion. After a graft segment was explanted 41 
months later, this specimen was processed tbr 
light, scanning, and transmission electron micros- 
copy. All samples were rinsed in warm (37 ° C) 
Hank's balanced salt solution (JHR, Biosciences) 
before being transferred into the respective fixa- 
tives. One half of each specimen was placed into 
2% glutaraldehyde (0.05M Cacodylate buffer/pH 
7.2/4 ° C), whereas the other one was fixed in 4% 
formalin (0.1 mol /L  phosphate-buffered saline so- 
lut ion/pH 7.2/4 ° C). 
Light microscopy. After fixation was pertbrmed 
in buffered formalin, samples were embedded in par- 
affin. Sections 3 I~m thick were stained with hema- 
toxylin-eosin, Orcein's stain tbr elastic fibers, and 
Masson's trichrome stain. 
Immunohistochemistry. All immunohistochemi- 
cal stainings were performed on paraffm-embedded 
material with the alkaline-anti-alkaline-phosphatase 
(APAAP) technique. The antibodies used and their 
main reactivity are listed in Table I. The staining reac- 
tion was achieved with Fast Red TR (Sigma) and Naph- 
tol-AS-MX-Phosphate in an 0.1 mol/L Tris-buffer (pH 
8.2). Finally, the sections were lightly counterst~aed 
with hematoxylin. 
SEM. Samples for SEM were dehydrated in 
graded ethanol, critical point-dried (CPD 20; Balz- 
ers, Liechtenstein), and investigated with a Philips 
SEM 505 (Philips, Eindhoven, The Netherlands). 
Transmission electron microscopy. Specimens 
from three different sites of the explantcd graft 
segment were taken for transmission electron mi- 
croscopy; two of these were from areas that ap- 
peared normal, whereas the third one was from the 
atherosclerotic lesion. After standard osmification 
and embedding procedures were performed, the 
Table I. Immunohistochemical analysis 
Antibody Main reactivi~ Specific findings 
QBEnd 10 
(CD34)* 
JC 70/A 
(CD 31 ) 
vWF 
( F VIII :rAg )]" 
Acfnl  
Dcsmin~ 
Collagen WI" 
KP I 
(CD 68)t 
PG M1 
(CD 68)"f 
Endothelial cells Intaa cndothelial layer 
Haematopoietic cells Neovascularization only 
in fibrous plaques 
No transprosthetic 
in~oxwth 
Endothelial cells 
Endothelial cells 
All muscle cells Numerous positive cells in 
Mvofibroblasrs the tissue layer between 
Myocpithelial cells endothelium and graft 
Smooth-muscle c lls 
Skeletal muscle cells 
Basement membrane Intact basement membrane 
beneath the endothelium 
Monocxlcs Lipoid macrophages 
Histi(~-vtes exdusivdy inatheromatous 
Mvcloic Cells areas 
Monocvtes 
Histiot-v[es 
Eight diffierent imnmnohistochemical stains were used to charac- 
terize the intima and neo-media of the explanted in vitro endothe- 
lialized graft segment. The findings are compared with the speci- 
ficity of the various antibodies. 
*Novocastra; Newcastle Upon Tyne; U.K. 
J'Dalco; Glostrup; Denmark. 
specimens were investigated with a TEM 420 
(Philips). 
RESULTS 
Histologic and ultrastructural findings 
Preimplantation morphologic haracteristics 
Light microscopy. Histologic cross sections of 
freshly lined grafts and preimplantation control grafts 
showed avon Willebrand positive, confluent endo- 
thelial cell layer resting on a homogenous and evenly 
covering protein matrix. The thickness of the under- 
lying fibrin glue matrix was 7.3 Ixm and 7.0 Ixm in 
the left graft and 8.1 txm and 8.3 txm in the right 
one. 
SEM. Both grafts showed a completely covering, 
confluent cndothelium at the cnd of the lining pro- 
cedure. By the time of implantation the endothelium 
still conflucntly covered the entire surface. The SEM 
appearance of thcse cells was more mature with bet- 
ter pronounccd marginal ovcrlapping. 
Post implantation morphologic haracteristics 
Gross examination. The outer surface of the 
ePTFE graft was completely enclosed by a dense, 
whitish fibrous tissue. The inner surface of the entire 
specimen was smooth, grey-white, and showed mul- 
tiple yellow and white plaques resembling native ath- 
erosclerosis. In the midportion of the graft these 
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Fig. 2. Confluent monolayer of CD 34 positive ndothe- 
lial cells resting on well-developed neo-media. Structure of 
ePTFE graft is clearly visible underneath (APAP tech- 
nique/X200). 
i C i 
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Fig. 4. Border area between nondiseased part of in vitro 
lined ePTFE graft and atheromatous lesion. Well-defined 
internal elastic membrane (left) gets disintegrated (right) to- 
gether with increasing intimal thickening (Orcein/200 ×). 
iiiiii: ii: • 
Fig. 3. Immunohistochemical proof of presence of actin 
in cells of subintimal tissue layer. N gative staining of cell 
monolayer at surface (APAP technique/200×). 
plaques ignificantly narrowed the lumen. The strik- 
ing similarity with a native artery with atherosclerotic 
plaques was obvious. 
Light microscopy and immunohistochemistry (Ta- 
ble I). Histologic cross sections showed the inner 
surface being completely covered by a single layer of 
flattened cells typical for an endothelium. These cells 
were strongly positive for von Willebrand factor, CD 
31, and CD 34 (Table I; Fig. 2). Between this endo- 
thelium and the graft a continuous tissue layer of 
1.21 + 0.19 mm thickness was demonstrable, show- 
ing histologic and immunohistochemical riteria of a 
tunica media and intima. It contained numerous 
Fig. 5. Intimal plaque protruding into lumen of in vitro 
endothelialized prostheses. CD-68 positive foamy macro- 
phages in depth of neo-media close to ePTFE graft are 
found only in this area (APAP technique/200 x ). 
actin- (Fig. 3) and desmin-positive c lls resembling 
smooth muscle cells. A well-developed internal elas- 
tic membrane could regularly be found underneath 
the collagen IV-positive basement membrane of  the 
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Fig. 6. Transmission electron micrograph of unaffected part of in vitro endothelialized graft. 
Well-differentiated ndothelium rests on collagen-rich subendothelial matrix. Cytoplasm shows 
numerous Weibl-Pallade bodies (@) and normal organelles. Complex intercellular contact ( ) 
and incompletely visible basal lamina (V) (transmission electron microsc py/×33,000). 
endothelium (Fig. 4). In atheromatous areas the 
internal elastic membrane was disintegrated to vari- 
ous degrees (Fig. 4). 
The outside of the graft was surrounded by a rim 
of histiocytes with numerous multinucleated giant 
cells. The prostheses itself was intact, and neither 
showed macrophage infiltration nor capillary in- 
growth. In addition, multiple fatty streaks, fibrous 
plaques, and atheromas indistinguishable from con- 
ventional atherosclerotic lesions were developed. 
Only in these areas KP-1- and MG-Ml-positive 
foamy macrophages could be demonstrated (Fig. 5). 
A neovascularization of the intima by small capillaries 
ingrowing from the luminal surface of the graft was 
found only in fibrous plaques but not in the unaf- 
fected parts of the graft. 
SEM. The entire graft segment was covered by a 
mature confluent endothelinm. These endothelial cells 
showed numerous microvilli and pronounced marginal 
overlapping. The surface was free of thrombotic adher- 
ences, either fibrin or platelets. Areas with macroscopi- 
cally visible plaques where characterized bysurface pro- 
tmsions approximately 1 mm in diameter. These 
protrusions were only partially covered by an intact 
endothclium whose cells were polygonal. In contrast to 
the unaffected graft areas, highly polarized leukocytes 
were adherent. Occasionally only lamellopodias of 
these leukocytes were visible, indicating subendothelial 
leukocyte migration. Between these endothelial rem- 
nants the subendothelial matrix was openly exposed. 
Transmission electron microscopy. Except for 
plaque areas the graft surface was covered by a well- 
differentiated endothelium with typical organelles 
(Fig. 6). Numerous Weibel-Pallade bodies were reg- 
ularly present, particularly in the periphery of the 
cells (Fig. 6). Confluence was maintained through 
complex intercellular contacts. In immediate prox- 
imity to the endothelial cells a delicate and noncon- 
t inuous basal membrane was found. The endothe- 
lium and its basal membrane rested on a dense 
network of collagen fibrils. Underneath the internal 
elastic membrane the subintimal matrix was charac- 
terized by mature myofibroblasts often embedded in
densely packed collagen strands (Fig. 7). Most of 
these myofibroblasts displayed features of myocytes 
(Fig. 7). Nevertheless a number of these cells also 
showed characteristics of secretory cells: a well-devel- 
oped Golgi-complex and a pronounced endoplasmic 
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Fig. 7. Mature myofibroblasts from depth of subintimal tissue layer with few perinuclear 
organelles and well-differentiated actin filament system at periphery (transmission electron 
microscopy/X47,000). 
reticulum. In the proximity of a plaque and its foamy 
macrophages these cells contained strikingly large 
lipid vacuoles. 
DISCUSSION 
With the opportunity to investigate a 41-month 
implant we were eventually able to substantiate the 
clinical success of in vitro endothelialization s with 
morphologic longoterm evidence. We could show 
that in vitro lined grafts maintain an intact endothe- 
lial coverage ven after 31/2 years of implantation. 
Unexpected, however, was the finding that despite 
pure endothelial cell lining, a cell-rich matrix had 
developed between the prosthesis and the ndothe- 
lium throughout the graft. The cells of this matrix 
were rich in actin and were separated from the intima 
by a true internal elastic membrane that distin- 
guished them from a neo-intima. Because untreated 
ePTFE grafts do not develop a tissue layer on their 
luminal side, it is evident hat this subintimal tissue 
was enabled or caused by the in vitro lining proce- 
dure. Considering the fact that cell ingrowth or col- 
onization of standard ePTFE grafts is limited to the 
immediate pcrianastomotic region, the three princi- 
pal options for the origin of  the subintimal tissue 
were coseeding during the initial endothelialization 
process, subendothelial migration from the adjacent 
artery, or colonization from the blood. 
Apart from the desire to explain the origin of this 
subintimal tissue, another question seems to be of  
imminent practical importance: does this tissue for- 
mation represent a pathologic process in the sense of  
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a non-self-limiting hyperplastic cell proliferation or 
self-limiting tissue remodeling? To answer this ques- 
tion mixed microvascular seeding seems to provide 
an explanatory analogy. When Park et al. 8 presented 
a case report on a human prosthesis eeded with 
microvascular cells, an unusually thick subendothe- 
lial cell layer had raised exactly the same concern. To 
clarify this issue we previously performed a long-term 
follow-up of  tissue development after mixed micro- 
vascular seeding. 9 The major outcome of this study 
was the concurrence of two events: the maturation of 
the subendothelial cell matrix from fibroblastoid to- 
wards myocytoid and the accomplishment of an 
equilibrium of cell proliferation. In this case report 
the cell matrix was also dominated by surprisingly 
mature contractile cells. Furthermore the thickness 
of the subintimal cell matrix correlated well with that 
of a native tunica media and was also evenly devel- 
oped throughout the graft without areas ofstenosing 
hyperplasia. 
After the long-lasting disputes of the 1980s over 
the method of  choice for actively achieving graft 
endothelialization, it is exciting to see that two meth- 
ods as diverse as in vitro lining and mixed microvas- 
cular seeding may eventually lead to an identical 
result: the healing of a prosthetic graft accompanied 
by a selfqimiting initial tissue proliferation, cell dif- 
ferentiation, and endothelialization. This realization 
further underlines the current redefinition of stand- 
points in prosthetic graft research. In contrast o 
previous beliefs, host tissue appears to be capable of 
incorporating synthetic grafts provided some sort of 
active intervention helps overcome initial ingrowth 
inhibitions. Apart from controlling the inflammatoqr 
response and the resulting fibrosis, the definition of 
these initiation factors will be a key to spontaneously 
healing grafts. All nonbiologic aspects like compli- 
ance or porosity, as important as they might be, will 
certainly be solved as soon as the biologic key to 
ingrowth facilitation has been tbund. Nevertheless it 
is well possible that these nonbiologic aspects are the 
limiting factors of  currently available methods of 
graft endothelialization: both noncompliance and 
low porosity might well be responsible tbr the lack of 
complete differentiation of myofibroblasts o myo- 
cytes and for the early appearance of true atheroscle- 
rotic lesions in one of our endothelialized prosthetic 
grafts. 
For the time being in vitro endothelialization 
offers not only a method that improves the patency of 
clinically implanted bypass grafts but also results in a 
mature tissue coverage whereby a confluent endo- 
thelium rests on a true internal elastic membrane and 
a mature subintimal cell matrix. 
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